At Eurofins Central Laboratory, we are the End-to-End solution to the BioPharma industry! With our four standardized, wholly-owned global locations [US, Netherlands, Singapore, China] and a back office in India, we provide CAP/CLIA certified analytical services in both a GCP and GCLP environment. This allows us to combine safety and efficacy analysis with Biomarker Services embedded within one laboratory, introducing cost efficiencies into Sponsor study budgets, and increasing specimen integrity by reducing unnecessary transport.
Reliable, high-quality laboratory data is pivotal to the success of clinical trials. It’s the RESULTS THAT MATTER. Since laboratory testing is our sole focus, we go above and beyond to provide an array of services to ensure that any clinical trial sample is collected, transported, managed, analyzed, reported and stored to meet the objectives and purpose of each study. We are dedicated to providing the most cost effective and efficient solutions to pharmaceutical and biotech companies, and CROs alike.
What differentiates Eurofins from the rest? Innovation. Whether that is our specimen visibility tool, EzRF (web-based requisition), our home-based, virtual trial patient specimen collection kits or our mobile laboratory technician service for standardized CAP certified on-site analysis of rapid analytical TAT requirements (PBMC, semen analysis, virology specimen processing), Eurofins Central Laboratory is your analytical solution for Phase 1 to 4 clinical trials.
The Evolution of the Central Lab
As part of our Biopharma division, Eurofins central lab has amassed more than 20 years’ experience. Our clients benefit from the fact that we are part of one of the world’s leading lab organizations. This means you’ll enjoy end-to-end testing solutions, free from the worry of coordinating multiple vendors. Our testing capabilities are unsurpassed and we are setting new standards with our GCLP capabilities embedded within the Central Lab.
Come on, give Eurofins a try…
In 1987, Dr. Gilles Martin created Eurofins Scientific as a high-tech university spin-off to offer the SNIF-NMR® technology to a broad audience. Originally developed to detect the chaptalization of French wines, the technology could now authenticate the origin and purity of a large number of food products including fruit juices and sugar-containing products such as honey, jam, alcoholic beverages, flavors and more recently to non-food products such as cosmetics, chemicals and pharmaceuticals.
Over the next few years, Eurofins progressed from a small operation in Nantes with little more than a dozen employees to a leading international life sciences company with about 55,000 staff in more than 900 laboratories across 50 countries in North America, South America, Europe and Asia-Pacific. Today, Eurofins Scientific performs over 400 million tests every year providing testing services to three distinct industries, Biopharma, Food and Environment and offers a portfolio of over 200,000 analytical methods. This includes over 25 million PCR tests carried out since the start of the pandemic.